Neumora Therapeutics, Inc. Common Stock Insider Transactions
Neumora Therapeutics, Inc. Common Stock Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Fust Matthew K
Director |
Sell | 14,049 @ $17.03 | $239,319 | 20,100 | 10/18/2024 | 10/18/2024 | |
|
Fust Matthew K
Director |
Sell | 7,739 @ $17.01 | $131,643 | 20,100 | 10/17/2024 | 10/18/2024 | |
|
Lenz Robert A.
Head of R&D |
Sell | 8,260 @ $15.09 | $124,603 | 314,706 | 10/10/2024 | 10/11/2024 | |
|
Lenz Robert A.
Head of R&D |
Sell | 5,563 @ $15.01 | $83,507 | 322,966 | 10/09/2024 | 10/11/2024 | |
|
Lenz Robert A.
Head of R&D |
Sell | 10,676 @ $12.09 | $129,091 | 328,529 | 09/18/2024 | 09/19/2024 | |
|
Lenz Robert A.
Head of R&D |
Sell | 30,788 @ $11.81 | $363,736 | 339,205 | 09/17/2024 | 09/19/2024 | |
|
Lenz Robert A.
Head of R&D |
Sell | 32,948 @ $11.43 | $376,665 | 369,993 | 09/12/2024 | 09/16/2024 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 3,357 @ $11.98 | $40,217 | 4,131,207 | 11/14/2023 | 11/15/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 3,357 @ $11.98 | $40,217 | 4,131,207 | 11/14/2023 | 11/15/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 31,653 @ $11.75 | $371,923 | 4,127,850 | 11/13/2023 | 11/15/2023 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 31,653 @ $11.75 | $371,923 | 4,127,850 | 11/13/2023 | 11/15/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 5,431 @ $11.75 | $63,814 | 4,096,197 | 11/10/2023 | 11/13/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 11,844 @ $11.37 | $134,666 | 4,090,766 | 11/10/2023 | 11/13/2023 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 5,431 @ $11.75 | $63,814 | 4,096,197 | 11/10/2023 | 11/13/2023 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 11,844 @ $11.37 | $134,666 | 4,090,766 | 11/10/2023 | 11/13/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 31,079 @ $10.53 | $327,262 | 4,078,922 | 11/09/2023 | 11/13/2023 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 31,079 @ $10.53 | $327,262 | 4,078,922 | 11/09/2023 | 11/13/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 23,124 @ $11.79 | $272,632 | 4,047,843 | 11/08/2023 | 11/13/2023 | |
|
ARCH Venture Partners XII, LLC
10 percent owner |
Buy | 69,127 @ $10.78 | $745,189 | 4,024,719 | 11/08/2023 | 11/13/2023 | |
|
Burow Kristina
Director, 10 percent owner: |
Buy | 69,127 @ $10.78 | $745,189 | 4,024,719 | 11/08/2023 | 11/13/2023 |
Neumora Therapeutics, Inc. Common Stock FAQ's
Who is on Neumora Therapeutics, Inc. Common Stock's Insider Roster?
The list of insiders at Neumora Therapeutics, Inc. Common Stock includes Lenz Robert A., Fust Matthew K.
How much insider selling is happening at Neumora Therapeutics, Inc. Common Stock?
Insiders have sold a total of 110,023 Neumora Therapeutics, Inc. Common Stock shares in the last 12 months for a total of 1.45 M sold.
Which Neumora Therapeutics, Inc. Common Stock insiders have been selling company stock?
The following insiders have sold Neumora Therapeutics, Inc. Common Stock shares in the last 12 months: Lenz Robert A. ($1.08 M), Fust Matthew K ($370,962),